| Primary |
| Drug Use For Unknown Indication |
25.0% |
| Acute Coronary Syndrome |
10.0% |
| Hypertension |
9.1% |
| Product Used For Unknown Indication |
8.2% |
| Antiplatelet Therapy |
5.3% |
| Cardiovascular Event Prophylaxis |
4.0% |
| Atrial Fibrillation |
3.9% |
| Prophylaxis |
3.9% |
| Thrombosis Prophylaxis |
3.8% |
| Coronary Artery Disease |
3.7% |
| Myocardial Infarction |
3.6% |
| Anticoagulant Therapy |
3.4% |
| Coronary Arterial Stent Insertion |
2.8% |
| Myocardial Ischaemia |
2.4% |
| Diabetes Mellitus |
2.3% |
| Pain |
1.9% |
| Suicide Attempt |
1.9% |
| Acute Myocardial Infarction |
1.7% |
| Depression |
1.5% |
| Ill-defined Disorder |
1.5% |
|
| Angioedema |
31.3% |
| Completed Suicide |
11.8% |
| Drug Toxicity |
8.1% |
| Gastrointestinal Haemorrhage |
6.8% |
| Melaena |
3.9% |
| Anaemia |
3.8% |
| Cerebral Haemorrhage |
3.8% |
| Death |
3.4% |
| Rash |
3.4% |
| Gastric Ulcer |
3.0% |
| Eye Swelling |
2.8% |
| Periorbital Oedema |
2.6% |
| Upper Gastrointestinal Haemorrhage |
2.3% |
| Vomiting |
2.3% |
| Epistaxis |
2.1% |
| Rectal Haemorrhage |
1.9% |
| Urticaria |
1.9% |
| Haematemesis |
1.7% |
| Haemorrhage Intracranial |
1.7% |
| Ischaemic Stroke |
1.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.9% |
| Product Used For Unknown Indication |
14.7% |
| Hypertension |
12.7% |
| Pain |
4.5% |
| Essential Thrombocythaemia |
4.0% |
| Atrial Fibrillation |
3.7% |
| Anticoagulant Therapy |
3.6% |
| Prophylaxis |
3.5% |
| Coronary Artery Disease |
3.4% |
| Diabetes Mellitus |
3.4% |
| Myocardial Infarction |
3.2% |
| Thrombosis Prophylaxis |
3.0% |
| Coronary Arterial Stent Insertion |
2.8% |
| Acute Myocardial Infarction |
2.6% |
| Acute Coronary Syndrome |
2.5% |
| Type 2 Diabetes Mellitus |
2.4% |
| Antiplatelet Therapy |
2.3% |
| Myocardial Ischaemia |
2.0% |
| Blood Cholesterol Increased |
1.9% |
| Cardiac Failure |
1.9% |
|
| Drug Hypersensitivity |
10.9% |
| Gastrointestinal Haemorrhage |
9.9% |
| Completed Suicide |
9.2% |
| Thrombosis In Device |
6.1% |
| Vomiting |
5.5% |
| Renal Failure Acute |
5.1% |
| Suicide Attempt |
4.8% |
| Anaemia |
4.4% |
| Death |
4.4% |
| Haemorrhage |
4.4% |
| Jaundice |
4.4% |
| Drug Ineffective |
4.1% |
| Haemoptysis |
3.8% |
| Weight Decreased |
3.8% |
| Cerebral Haemorrhage |
3.4% |
| Multiple Drug Overdose |
3.4% |
| Mean Arterial Pressure Decreased |
3.1% |
| Myocardial Infarction |
3.1% |
| Rectal Haemorrhage |
3.1% |
| Upper Gastrointestinal Haemorrhage |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
39.0% |
| Product Used For Unknown Indication |
17.1% |
| Hypertension |
9.4% |
| Rheumatoid Arthritis |
4.7% |
| Blood Cholesterol Increased |
4.0% |
| Coronary Artery Bypass |
3.9% |
| Diabetes Mellitus |
3.0% |
| Prophylaxis |
2.7% |
| Pain |
2.4% |
| Depression |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Multiple Myeloma |
1.4% |
| Cardiac Disorder |
1.4% |
| Coronary Artery Disease |
1.3% |
| Atrial Fibrillation |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Blood Cholesterol |
1.1% |
| Vitamin Supplementation |
1.0% |
| Aortic Valve Replacement |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Pain |
9.3% |
| Flushing |
8.9% |
| Pruritus |
7.5% |
| Vomiting |
7.0% |
| Injury |
6.8% |
| Myocardial Infarction |
5.8% |
| Unevaluable Event |
5.3% |
| Weight Increased |
5.2% |
| Weight Decreased |
4.9% |
| Fear |
4.8% |
| Renal Failure |
4.4% |
| Anhedonia |
3.9% |
| Paraesthesia |
3.9% |
| Anxiety |
3.7% |
| Syncope |
3.7% |
| Pain In Extremity |
3.5% |
| Nausea |
3.2% |
| Vision Blurred |
2.8% |
| Pneumonia |
2.8% |
| Tremor |
2.7% |
|
| Interacting |
| Acute Coronary Syndrome |
16.3% |
| Product Used For Unknown Indication |
13.2% |
| Drug Use For Unknown Indication |
11.7% |
| Hypertension |
9.8% |
| Myocardial Infarction |
8.5% |
| Pain |
5.1% |
| Depression |
4.9% |
| Coronary Artery Disease |
4.6% |
| Atrial Fibrillation |
3.2% |
| Dementia |
3.2% |
| Ill-defined Disorder |
2.7% |
| Anticoagulant Therapy |
2.4% |
| Prophylaxis |
2.4% |
| Chalazion |
2.2% |
| Dementia With Lewy Bodies |
2.0% |
| Pulmonary Embolism |
2.0% |
| Asthma |
1.5% |
| Blood Pressure Increased |
1.5% |
| Cardiac Failure |
1.5% |
| Deep Vein Thrombosis |
1.5% |
|
| Drug Interaction |
22.1% |
| Gastrointestinal Haemorrhage |
11.8% |
| Renal Failure Acute |
8.8% |
| Delirium |
5.9% |
| Post Procedural Haemorrhage |
5.9% |
| Haematochezia |
4.4% |
| Pleural Effusion |
4.4% |
| Anal Fistula |
2.9% |
| Drug Ineffective |
2.9% |
| Duodenal Ulcer |
2.9% |
| Gastritis |
2.9% |
| Haemorrhage |
2.9% |
| Hyperglycaemia |
2.9% |
| Intraocular Pressure Increased |
2.9% |
| Loss Of Consciousness |
2.9% |
| Myocardial Infarction |
2.9% |
| Nervous System Disorder |
2.9% |
| Prescribed Overdose |
2.9% |
| Thrombosis |
2.9% |
| Abdominal Distension |
1.5% |
|
